ID: ALA3911439

Max Phase: Preclinical

Molecular Formula: C14H17N3OS

Molecular Weight: 275.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Cc1ccc(S)cc1)NCCCn1ccnc1

Standard InChI:  InChI=1S/C14H17N3OS/c18-14(10-12-2-4-13(19)5-3-12)16-6-1-8-17-9-7-15-11-17/h2-5,7,9,11,19H,1,6,8,10H2,(H,16,18)

Standard InChI Key:  YMFUYDUYVVDPRN-UHFFFAOYSA-N

Associated Targets(non-human)

Lipoprotein lipase 268 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 275.38Molecular Weight (Monoisotopic): 275.1092AlogP: 1.92#Rotatable Bonds: 6
Polar Surface Area: 46.92Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.20CX Basic pKa: 6.92CX LogP: 0.26CX LogD: 0.07
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.62Np Likeness Score: -1.69

References

1. Geldenhuys WJ, Caporoso J, Leeper TC, Lee YK, Lin L, Darvesh AS, Sadana P..  (2017)  Structure-activity and in vivo evaluation of a novel lipoprotein lipase (LPL) activator.,  27  (2): [PMID:27913180] [10.1016/j.bmcl.2016.11.053]

Source